Skip Navigation
Johns Hopkins Bloomberg School of Public HealthCAAT

2005 Recognition Awards

Julia H. Fentem, PhD

The CAAT Recognition Award, presented at each World Congress, honors an individual (or organization) who has made an outstanding contribution to the field of the 3Rs, the development of alternative methods, or the field of in vitro science.

Dr. Fentem, executive member of the Safety and Environmental Assurance Centre (SEAC) and internal expert on alternatives at Unilever, was chosen from a strong field of international nominees for her "outstanding contributions to the advancement of replacement alternatives."

Prior to joining Unilever, Dr. Fentem served as a scientific officer and as an expert toxicologist at the Fund for the Replacement of Animals in Medical Experiments (FRAME) and at the European Centre for the Validation of Alternative Methods (ECVAM). With an extraordinary ability to translate her experiences in academic and regulatory settings into corporate policy, she has had a profound impact on how the corporate sector thinks about alternatives.

Previous recipients of CAAT Recognition Awards include: Robert A. Scala, Herman B.W.M. Koeter, Andrew N. Rowan; Gerhard Zbinden, Per Ottar Seglen, Procter & Gamble Co., Avon Products Inc., Zeneca, Michael F.W. Festing, and Paul Flecknell.

Since 1981, CAAT has supported the development of alternatives that refine methods to make them less painful or stressful, reduce the number of animals necessary for a particular experiment, or replace them with a non-whole animal method. In 2001, CAAT launched a new Refinement Program Project focused on the identification, assessment, and elimination of pain and distress in laboratory animals.